Loading…
Cyclooxygenase-2 induction by bradykinin in aortic vascular smooth muscle cells
Departamento de Fisiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile Submitted 8 April 2005 ; accepted in final form 31 August 2005 Vascular smooth muscle cell proliferation and migration play an important role in the pathophysiology of several vascu...
Saved in:
Published in: | American journal of physiology. Heart and circulatory physiology 2006-01, Vol.290 (1), p.H30-H36 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c457t-fda06a1ed889b70a65c4e8f1f56385859ec020b9cbc06679255ae8ee4a6c7fe23 |
---|---|
cites | cdi_FETCH-LOGICAL-c457t-fda06a1ed889b70a65c4e8f1f56385859ec020b9cbc06679255ae8ee4a6c7fe23 |
container_end_page | H36 |
container_issue | 1 |
container_start_page | H30 |
container_title | American journal of physiology. Heart and circulatory physiology |
container_volume | 290 |
creator | Rodriguez, Jorge A De la Cerda, Paula Collyer, Eileen Decap, Valerie Vio, Carlos P Velarde, Victoria |
description | Departamento de Fisiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile
Submitted 8 April 2005
; accepted in final form 31 August 2005
Vascular smooth muscle cell proliferation and migration play an important role in the pathophysiology of several vascular diseases, including atherosclerosis. Prostaglandins that have been implicated in this process are synthesized by two isoforms of cyclooxygenase (COX), with the expression of the regulated COX-2 isoform increased in atherosclerotic plaques. Bradykinin (BK), a vasoactive peptide increased in inflammation, induces the formation of prostaglandins through specific receptor activation. We hypothesized that BK plays an important role in the regulation of COX-2, contributing to the increase in production of prostaglandins in vascular smooth muscle cells. Herein we examined the signaling pathways that participate in the BK regulation of COX-2 protein levels in primary cultured aortic vascular smooth muscle cells. We observed an increase in COX-2 protein levels induced by BK that was maximal at 24 h. This increase was blocked by a B2 kinin receptor antagonist but not a B1 receptor antagonist, suggesting that the B2 receptor is involved in this pathway. In addition, we conclude that the activation of mitogen-activated protein kinases p42/p44, protein kinase C, and nitric oxide synthase is necessary for the increase in COX-2 levels induced by BK because either of the specific inhibitors for these enzymes blocked the effect of BK. Using a similar approach, we further demonstrated that reactive oxygen species and cAMP were not mediators on this pathway. These results suggest that BK activates several intracellular pathways that act in combination to increase COX-2 protein levels. This study suggests a role for BK on the evolution of the atheromatous plaque by virtue of controlling the levels of COX-2.
atherosclerosis; signal transduction; antioxidants
Address for reprint requests and other correspondence: V. Velarde, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Alameda 340, PO Box 114D, Santiago, Chile (e-mail: mvelarde{at}bio.puc.cl ) |
doi_str_mv | 10.1152/ajpheart.00349.2005 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmed_primary_16143655</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67588204</sourcerecordid><originalsourceid>FETCH-LOGICAL-c457t-fda06a1ed889b70a65c4e8f1f56385859ec020b9cbc06679255ae8ee4a6c7fe23</originalsourceid><addsrcrecordid>eNp1kMtOwzAQRS0EgvL4AiSUFbsUP2InWaIKKBISG1hbjjNpXJw42AmQvyelpaxYWRqfc2d0EbokeE4Ipzdq3dWgfD_HmCX5nGLMD9Bs-qEx4Sw_RDPMBIsFYfwEnYawxhORCnaMToggCROcz9DzYtTWua9xBa0KENPItOWge-PaqBijwqtyfDOtaad5pJzvjY4-VNCDVT4KjXN9HTVD0BYiDdaGc3RUKRvgYveeodf7u5fFMn56fnhc3D7FOuFpH1elwkIRKLMsL1KsBNcJZBWpuGAZz3gOGlNc5LrQWIg0p5wryAASJXRaAWVn6Hqb23n3PkDoZWPC5gLVghuCFCnPMoqTCWRbUHsXgodKdt40yo-SYLnpUf72KH96lJseJ-tqFz8UDZR_zq64Cci3QG1W9afxILt6DMZZtxrl_WDtC3z1-2iaT7vkkmHZldXkxv-7-2v2DvsGiGyXWQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67588204</pqid></control><display><type>article</type><title>Cyclooxygenase-2 induction by bradykinin in aortic vascular smooth muscle cells</title><source>American Physiological Society Free</source><creator>Rodriguez, Jorge A ; De la Cerda, Paula ; Collyer, Eileen ; Decap, Valerie ; Vio, Carlos P ; Velarde, Victoria</creator><creatorcontrib>Rodriguez, Jorge A ; De la Cerda, Paula ; Collyer, Eileen ; Decap, Valerie ; Vio, Carlos P ; Velarde, Victoria</creatorcontrib><description>Departamento de Fisiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile
Submitted 8 April 2005
; accepted in final form 31 August 2005
Vascular smooth muscle cell proliferation and migration play an important role in the pathophysiology of several vascular diseases, including atherosclerosis. Prostaglandins that have been implicated in this process are synthesized by two isoforms of cyclooxygenase (COX), with the expression of the regulated COX-2 isoform increased in atherosclerotic plaques. Bradykinin (BK), a vasoactive peptide increased in inflammation, induces the formation of prostaglandins through specific receptor activation. We hypothesized that BK plays an important role in the regulation of COX-2, contributing to the increase in production of prostaglandins in vascular smooth muscle cells. Herein we examined the signaling pathways that participate in the BK regulation of COX-2 protein levels in primary cultured aortic vascular smooth muscle cells. We observed an increase in COX-2 protein levels induced by BK that was maximal at 24 h. This increase was blocked by a B2 kinin receptor antagonist but not a B1 receptor antagonist, suggesting that the B2 receptor is involved in this pathway. In addition, we conclude that the activation of mitogen-activated protein kinases p42/p44, protein kinase C, and nitric oxide synthase is necessary for the increase in COX-2 levels induced by BK because either of the specific inhibitors for these enzymes blocked the effect of BK. Using a similar approach, we further demonstrated that reactive oxygen species and cAMP were not mediators on this pathway. These results suggest that BK activates several intracellular pathways that act in combination to increase COX-2 protein levels. This study suggests a role for BK on the evolution of the atheromatous plaque by virtue of controlling the levels of COX-2.
atherosclerosis; signal transduction; antioxidants
Address for reprint requests and other correspondence: V. Velarde, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Alameda 340, PO Box 114D, Santiago, Chile (e-mail: mvelarde{at}bio.puc.cl )</description><identifier>ISSN: 0363-6135</identifier><identifier>EISSN: 1522-1539</identifier><identifier>DOI: 10.1152/ajpheart.00349.2005</identifier><identifier>PMID: 16143655</identifier><language>eng</language><publisher>United States</publisher><subject>Adenylyl Cyclase Inhibitors ; Animals ; Aorta - cytology ; Aorta - drug effects ; Bradykinin - pharmacology ; Bradykinin B2 Receptor Antagonists ; Butadienes - pharmacology ; Cells, Cultured ; Cyclic AMP-Dependent Protein Kinases - antagonists & inhibitors ; Cyclooxygenase 2 - biosynthesis ; Dideoxyadenosine - analogs & derivatives ; Dideoxyadenosine - pharmacology ; Enzyme Induction - drug effects ; Imidazoles - pharmacology ; Immunohistochemistry ; Isoquinolines - pharmacology ; Male ; Mitogen-Activated Protein Kinase Kinases - antagonists & inhibitors ; Muscle, Smooth, Vascular - cytology ; Muscle, Smooth, Vascular - drug effects ; NG-Nitroarginine Methyl Ester - pharmacology ; Nitriles - pharmacology ; p38 Mitogen-Activated Protein Kinases - antagonists & inhibitors ; Protein Kinase C - antagonists & inhibitors ; Pyridines - pharmacology ; Rats ; Rats, Sprague-Dawley ; Receptor, Bradykinin B2 - physiology ; Sulfonamides - pharmacology</subject><ispartof>American journal of physiology. Heart and circulatory physiology, 2006-01, Vol.290 (1), p.H30-H36</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c457t-fda06a1ed889b70a65c4e8f1f56385859ec020b9cbc06679255ae8ee4a6c7fe23</citedby><cites>FETCH-LOGICAL-c457t-fda06a1ed889b70a65c4e8f1f56385859ec020b9cbc06679255ae8ee4a6c7fe23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16143655$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rodriguez, Jorge A</creatorcontrib><creatorcontrib>De la Cerda, Paula</creatorcontrib><creatorcontrib>Collyer, Eileen</creatorcontrib><creatorcontrib>Decap, Valerie</creatorcontrib><creatorcontrib>Vio, Carlos P</creatorcontrib><creatorcontrib>Velarde, Victoria</creatorcontrib><title>Cyclooxygenase-2 induction by bradykinin in aortic vascular smooth muscle cells</title><title>American journal of physiology. Heart and circulatory physiology</title><addtitle>Am J Physiol Heart Circ Physiol</addtitle><description>Departamento de Fisiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile
Submitted 8 April 2005
; accepted in final form 31 August 2005
Vascular smooth muscle cell proliferation and migration play an important role in the pathophysiology of several vascular diseases, including atherosclerosis. Prostaglandins that have been implicated in this process are synthesized by two isoforms of cyclooxygenase (COX), with the expression of the regulated COX-2 isoform increased in atherosclerotic plaques. Bradykinin (BK), a vasoactive peptide increased in inflammation, induces the formation of prostaglandins through specific receptor activation. We hypothesized that BK plays an important role in the regulation of COX-2, contributing to the increase in production of prostaglandins in vascular smooth muscle cells. Herein we examined the signaling pathways that participate in the BK regulation of COX-2 protein levels in primary cultured aortic vascular smooth muscle cells. We observed an increase in COX-2 protein levels induced by BK that was maximal at 24 h. This increase was blocked by a B2 kinin receptor antagonist but not a B1 receptor antagonist, suggesting that the B2 receptor is involved in this pathway. In addition, we conclude that the activation of mitogen-activated protein kinases p42/p44, protein kinase C, and nitric oxide synthase is necessary for the increase in COX-2 levels induced by BK because either of the specific inhibitors for these enzymes blocked the effect of BK. Using a similar approach, we further demonstrated that reactive oxygen species and cAMP were not mediators on this pathway. These results suggest that BK activates several intracellular pathways that act in combination to increase COX-2 protein levels. This study suggests a role for BK on the evolution of the atheromatous plaque by virtue of controlling the levels of COX-2.
atherosclerosis; signal transduction; antioxidants
Address for reprint requests and other correspondence: V. Velarde, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Alameda 340, PO Box 114D, Santiago, Chile (e-mail: mvelarde{at}bio.puc.cl )</description><subject>Adenylyl Cyclase Inhibitors</subject><subject>Animals</subject><subject>Aorta - cytology</subject><subject>Aorta - drug effects</subject><subject>Bradykinin - pharmacology</subject><subject>Bradykinin B2 Receptor Antagonists</subject><subject>Butadienes - pharmacology</subject><subject>Cells, Cultured</subject><subject>Cyclic AMP-Dependent Protein Kinases - antagonists & inhibitors</subject><subject>Cyclooxygenase 2 - biosynthesis</subject><subject>Dideoxyadenosine - analogs & derivatives</subject><subject>Dideoxyadenosine - pharmacology</subject><subject>Enzyme Induction - drug effects</subject><subject>Imidazoles - pharmacology</subject><subject>Immunohistochemistry</subject><subject>Isoquinolines - pharmacology</subject><subject>Male</subject><subject>Mitogen-Activated Protein Kinase Kinases - antagonists & inhibitors</subject><subject>Muscle, Smooth, Vascular - cytology</subject><subject>Muscle, Smooth, Vascular - drug effects</subject><subject>NG-Nitroarginine Methyl Ester - pharmacology</subject><subject>Nitriles - pharmacology</subject><subject>p38 Mitogen-Activated Protein Kinases - antagonists & inhibitors</subject><subject>Protein Kinase C - antagonists & inhibitors</subject><subject>Pyridines - pharmacology</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Receptor, Bradykinin B2 - physiology</subject><subject>Sulfonamides - pharmacology</subject><issn>0363-6135</issn><issn>1522-1539</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><recordid>eNp1kMtOwzAQRS0EgvL4AiSUFbsUP2InWaIKKBISG1hbjjNpXJw42AmQvyelpaxYWRqfc2d0EbokeE4Ipzdq3dWgfD_HmCX5nGLMD9Bs-qEx4Sw_RDPMBIsFYfwEnYawxhORCnaMToggCROcz9DzYtTWua9xBa0KENPItOWge-PaqBijwqtyfDOtaad5pJzvjY4-VNCDVT4KjXN9HTVD0BYiDdaGc3RUKRvgYveeodf7u5fFMn56fnhc3D7FOuFpH1elwkIRKLMsL1KsBNcJZBWpuGAZz3gOGlNc5LrQWIg0p5wryAASJXRaAWVn6Hqb23n3PkDoZWPC5gLVghuCFCnPMoqTCWRbUHsXgodKdt40yo-SYLnpUf72KH96lJseJ-tqFz8UDZR_zq64Cci3QG1W9afxILt6DMZZtxrl_WDtC3z1-2iaT7vkkmHZldXkxv-7-2v2DvsGiGyXWQ</recordid><startdate>20060101</startdate><enddate>20060101</enddate><creator>Rodriguez, Jorge A</creator><creator>De la Cerda, Paula</creator><creator>Collyer, Eileen</creator><creator>Decap, Valerie</creator><creator>Vio, Carlos P</creator><creator>Velarde, Victoria</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20060101</creationdate><title>Cyclooxygenase-2 induction by bradykinin in aortic vascular smooth muscle cells</title><author>Rodriguez, Jorge A ; De la Cerda, Paula ; Collyer, Eileen ; Decap, Valerie ; Vio, Carlos P ; Velarde, Victoria</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c457t-fda06a1ed889b70a65c4e8f1f56385859ec020b9cbc06679255ae8ee4a6c7fe23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Adenylyl Cyclase Inhibitors</topic><topic>Animals</topic><topic>Aorta - cytology</topic><topic>Aorta - drug effects</topic><topic>Bradykinin - pharmacology</topic><topic>Bradykinin B2 Receptor Antagonists</topic><topic>Butadienes - pharmacology</topic><topic>Cells, Cultured</topic><topic>Cyclic AMP-Dependent Protein Kinases - antagonists & inhibitors</topic><topic>Cyclooxygenase 2 - biosynthesis</topic><topic>Dideoxyadenosine - analogs & derivatives</topic><topic>Dideoxyadenosine - pharmacology</topic><topic>Enzyme Induction - drug effects</topic><topic>Imidazoles - pharmacology</topic><topic>Immunohistochemistry</topic><topic>Isoquinolines - pharmacology</topic><topic>Male</topic><topic>Mitogen-Activated Protein Kinase Kinases - antagonists & inhibitors</topic><topic>Muscle, Smooth, Vascular - cytology</topic><topic>Muscle, Smooth, Vascular - drug effects</topic><topic>NG-Nitroarginine Methyl Ester - pharmacology</topic><topic>Nitriles - pharmacology</topic><topic>p38 Mitogen-Activated Protein Kinases - antagonists & inhibitors</topic><topic>Protein Kinase C - antagonists & inhibitors</topic><topic>Pyridines - pharmacology</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Receptor, Bradykinin B2 - physiology</topic><topic>Sulfonamides - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rodriguez, Jorge A</creatorcontrib><creatorcontrib>De la Cerda, Paula</creatorcontrib><creatorcontrib>Collyer, Eileen</creatorcontrib><creatorcontrib>Decap, Valerie</creatorcontrib><creatorcontrib>Vio, Carlos P</creatorcontrib><creatorcontrib>Velarde, Victoria</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of physiology. Heart and circulatory physiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rodriguez, Jorge A</au><au>De la Cerda, Paula</au><au>Collyer, Eileen</au><au>Decap, Valerie</au><au>Vio, Carlos P</au><au>Velarde, Victoria</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cyclooxygenase-2 induction by bradykinin in aortic vascular smooth muscle cells</atitle><jtitle>American journal of physiology. Heart and circulatory physiology</jtitle><addtitle>Am J Physiol Heart Circ Physiol</addtitle><date>2006-01-01</date><risdate>2006</risdate><volume>290</volume><issue>1</issue><spage>H30</spage><epage>H36</epage><pages>H30-H36</pages><issn>0363-6135</issn><eissn>1522-1539</eissn><abstract>Departamento de Fisiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile
Submitted 8 April 2005
; accepted in final form 31 August 2005
Vascular smooth muscle cell proliferation and migration play an important role in the pathophysiology of several vascular diseases, including atherosclerosis. Prostaglandins that have been implicated in this process are synthesized by two isoforms of cyclooxygenase (COX), with the expression of the regulated COX-2 isoform increased in atherosclerotic plaques. Bradykinin (BK), a vasoactive peptide increased in inflammation, induces the formation of prostaglandins through specific receptor activation. We hypothesized that BK plays an important role in the regulation of COX-2, contributing to the increase in production of prostaglandins in vascular smooth muscle cells. Herein we examined the signaling pathways that participate in the BK regulation of COX-2 protein levels in primary cultured aortic vascular smooth muscle cells. We observed an increase in COX-2 protein levels induced by BK that was maximal at 24 h. This increase was blocked by a B2 kinin receptor antagonist but not a B1 receptor antagonist, suggesting that the B2 receptor is involved in this pathway. In addition, we conclude that the activation of mitogen-activated protein kinases p42/p44, protein kinase C, and nitric oxide synthase is necessary for the increase in COX-2 levels induced by BK because either of the specific inhibitors for these enzymes blocked the effect of BK. Using a similar approach, we further demonstrated that reactive oxygen species and cAMP were not mediators on this pathway. These results suggest that BK activates several intracellular pathways that act in combination to increase COX-2 protein levels. This study suggests a role for BK on the evolution of the atheromatous plaque by virtue of controlling the levels of COX-2.
atherosclerosis; signal transduction; antioxidants
Address for reprint requests and other correspondence: V. Velarde, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Alameda 340, PO Box 114D, Santiago, Chile (e-mail: mvelarde{at}bio.puc.cl )</abstract><cop>United States</cop><pmid>16143655</pmid><doi>10.1152/ajpheart.00349.2005</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0363-6135 |
ispartof | American journal of physiology. Heart and circulatory physiology, 2006-01, Vol.290 (1), p.H30-H36 |
issn | 0363-6135 1522-1539 |
language | eng |
recordid | cdi_pubmed_primary_16143655 |
source | American Physiological Society Free |
subjects | Adenylyl Cyclase Inhibitors Animals Aorta - cytology Aorta - drug effects Bradykinin - pharmacology Bradykinin B2 Receptor Antagonists Butadienes - pharmacology Cells, Cultured Cyclic AMP-Dependent Protein Kinases - antagonists & inhibitors Cyclooxygenase 2 - biosynthesis Dideoxyadenosine - analogs & derivatives Dideoxyadenosine - pharmacology Enzyme Induction - drug effects Imidazoles - pharmacology Immunohistochemistry Isoquinolines - pharmacology Male Mitogen-Activated Protein Kinase Kinases - antagonists & inhibitors Muscle, Smooth, Vascular - cytology Muscle, Smooth, Vascular - drug effects NG-Nitroarginine Methyl Ester - pharmacology Nitriles - pharmacology p38 Mitogen-Activated Protein Kinases - antagonists & inhibitors Protein Kinase C - antagonists & inhibitors Pyridines - pharmacology Rats Rats, Sprague-Dawley Receptor, Bradykinin B2 - physiology Sulfonamides - pharmacology |
title | Cyclooxygenase-2 induction by bradykinin in aortic vascular smooth muscle cells |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T07%3A17%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cyclooxygenase-2%20induction%20by%20bradykinin%20in%20aortic%20vascular%20smooth%20muscle%20cells&rft.jtitle=American%20journal%20of%20physiology.%20Heart%20and%20circulatory%20physiology&rft.au=Rodriguez,%20Jorge%20A&rft.date=2006-01-01&rft.volume=290&rft.issue=1&rft.spage=H30&rft.epage=H36&rft.pages=H30-H36&rft.issn=0363-6135&rft.eissn=1522-1539&rft_id=info:doi/10.1152/ajpheart.00349.2005&rft_dat=%3Cproquest_pubme%3E67588204%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c457t-fda06a1ed889b70a65c4e8f1f56385859ec020b9cbc06679255ae8ee4a6c7fe23%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=67588204&rft_id=info:pmid/16143655&rfr_iscdi=true |